Načítá se...
Effect of Aprotinin and Avifavir(®) Combination Therapy for Moderate COVID-19 Patients
COVID-19 is a contagious multisystem inflammatory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We studied the efficacy of Aprotinin (nonspecific serine proteases inhibitor) in combination with Avifavir(®) or Hydroxychloroquine (HCQ) drugs, which are recommended b...
Uloženo v:
| Vydáno v: | Viruses |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310315/ https://ncbi.nlm.nih.gov/pubmed/34199134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13071253 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|